pipette
ESEspañol

Aberrant erythrocyte rigidity in JAK2 V617F myeloproliferative neoplasms underlies concurrent thrombosis and hemorrhage

Aae Suzuki, Liang Zhao, Chelsea L. Thorsheim, Brittany Weiderhold, Changsong Yang, Valerie J. Tutwiler, Carla Casu, Jacob W. Myerson, Elizabeth Olson Hexner, Narla Mohandas, Vladimir R. Muzykantov, Rustem I. Litvinov, Chandrasekaran Nagaswami, Rebecca A Risman, Peng Ji, Timothy J. Stalker, Aaron R. Goldman, Hsin‐Yao Tang, David W. Speicher, Paul A. Janmey, Stefano B. Rivella, Wei Tong, John W. Weisel, Tatyana Svitkina, Charles S. Abrams

Peer-reviewed journalBold claims, read criticallyReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
These JAK2V617F-driven changes in erythropoiesis generated intrinsically rigid erythrocytes that impaired clot contraction and produced larger and more occlusive, yet mechanically unstable thrombi.

Appeared: Friday, October 9. Science Translational Medicine. Peer-reviewed journal.

DOI: 10.1126/scitranslmed.adt0044